Monday, April 16, 2018

Tiens Group boost China economy with global expansion

KUALA LUMPUR, April 16 (Bernama) -- Tiens Group´s chairman, Li Jinyuan highlighted the company´s global strategy and it's successful experiences from the Belt and Road Initiative at China's signature international economic meeting, The Boao Forum for Asia Annual Conference 2018 recently.

The event also gave the Tiens Group an open platform to attract all industries to focus on China.

With the conference theme of 'An Open and Innovative Asia for a World of Greater Prosperity', Li said that as the global economy has its eyes on China, China also had eyes on the world as well, a statement said.

The company has always been preparing for any opportunity and it will leverage the current trend to accelerate its preparation because it has long been at the forefront of globalisation, he said.

"Its accumulated experience over the years will greatly affect the long-term global development of enterprises. In response to this initiative, we are encouraging enterprises to take this opportunity to go global," added Li.

A media icon and the deputy general manager of Office of General Manager, Xinhua News Agency, Pan Haiping said Tiens Group represents one of China's 'going global' enterprises.

"After the Belt and Road Initiative was introduced, Tiens Group responded immediately and has opened up new markets in 37 countries and regions including the United States, Australia, France, Italy, Spain, South Korea, UAE, and the Philippines, " added Pan.

The expansion of the company has formed strategic alliances with outstanding companies in many countries around the world and set the industry benchmark for Chinese enterprises to successfully 'go global', Pan said.

The Boao Forum for Asia Annual Conference 2018 is the first China-hosted diplomatic activity this year. It is also a new starting point, with a number of heads of countries and world business leaders in attendance exceeding that of previous years, the statement added.

--BERNAMA

Tinubu Square restructures management team


KUALA LUMPUR, April 12 (Bernama) -- Tinubu Square is restructuring its management team following the recent EURO53 million (US$ 65.55 million) investment by Long Arc Capital and Bpifrance.

Tinubu Square´s strategy for 2018 is to expand its international footprint by enabling and supporting the digital transformation of specialty lines insurance and receivables financing amongst its existing and potential customers, a statement said.

The restructuring is marked by the appointment of group executive vice-president, Business Development, Bijan Olfati and co-founder of Tinubu Square, Olivier Placca as the new deputy chief executive officer (CEO) of the company.

Bijan Olfati, the former area vice-president, North America at Oracle Financial Services Global Business Unit will be responsible for growing global market share.

His expertise in financial services, data and enterprise risk management will be vital in helping Tinubu Square build a strong commercial and branding strategy.

The new deputy CEO, Olivier Placca will take over the day-to-day management of the company.

The appointment and restructure changes are part of Tinubu Square's global approach which will see its president, J?me Pez?ased in Canada, Bijan Olfati based in the United States and Olivier Placca remaining at the company's head office in Issy-les-Moulineaux near Paris.

Tinubu Square is the industry leader in trade credit, surety and receivables financing solution. The company is also a software vendor and enabler of the Trade Credit digital transformation. More information at www.tinubu.com.

--BERNAMA



Friday, April 13, 2018

CISCO TETRATION WORKLOAD PROTECTION EXTENDED WITH NEW OPTIONS: SAAS AND VIRTUAL APPLIANCE

New Tetration models deliver faster deployment and pay-as-you-grow flexibility
 
SAN JOSE, Calif., April 11 (Bernama-GLOBE NEWSWIRE) -- Cisco today announced two new consumption models for its Cisco® Tetration solution for the data center and cloud: Tetration SaaS, the cloud-based solution for cloud-first and cloud-only organizations, and Tetration-V, a software-only version using a virtual appliance for smaller deployments. Both models deliver the same features and functionality as the original on-premises form factors of Tetration. Tetration automates application dependency mapping and whitelist policy generation and enforcement, gives insight into network performance, and offers cloud workload protection. The Tetration  APIs enable IT organizations to create custom applications with access to Tetration data sources, allowing the export and enforcement of policies generated by Tetration across SDN controllers and security devices.

With the new consumption models, organizations can adopt Tetration technology within hours, with no initial investment and the flexibility to pay as they grow.

With Tetration SaaS, organizations gain the benefits of a fully managed model, including:
  • Workload protection features without any on-premises hardware requirements
  • Protection for on-premises, public, and private cloud workloads
  • Scalability up to 25,000 workloads
  • Data retention for months
  • Faster onboarding to realize the benefits of the platform quickly
  • Built-in high availability and disaster recovery capability
  • Service backed by world-class SLAs
  • Managed services provided by Cisco channel partners

For organizations that deploy fewer than 1000 workloads and prefer a software-only approach, Tetration is available on a virtual appliance. It offers one-click deployment and allows organizations to use their own server and storage infrastructure.

Both Tetration models deliver a ready-to-use solution to identify data center applications, their detailed dependencies, and the underlying policies between different application tiers. Operators can implement a zero-trust model using whitelist policy and segmentation, monitor the behavior of server processes, and identify software-related vulnerabilities. Tetration is able to identify high-severity security events such as certain Spectre and Meltdown exploits using behavior-based anomalies, allowing proactive quarantining of affected servers. With this approach, Tetration provides holistic cloud workload protection anywhere. For more information, see A Recipe to Keep Your Hybrid Cloud Workloads Safe.

“Cisco Tetration helps Xentaurs manage successful cloud and data center deployments for our clients by ensuring every single connection and flow to an application is visible,” said Anoj Willy, CEO, Xentaurs. “Without this critical information, app, cloud, and data center migrations would be impossible to precisely guarantee nothing is missed and everything is as it is intended. Tetration goes further in establishing and enforcing a zero-trust environment that is the foundation for microsegmentation, down to containers and next-generation services development.”

Cisco's architectural approach to security 
Tetration is also a core technology in Cisco’s data center security and workload protection portfolio. Tetration works with Cisco ACI and Cisco’s security portfolio, including Cisco Firepower® Next-Generation Firewall (NGFW), Next-Generation IPS (NGIPS), Advanced Malware Protection (AMP), and Stealthwatch® to deliver effective security that follows the workload everywhere. Now operators can see everything across their network, reduce the attack surface, and stop data center breaches from moving laterally across workloads.  For more information, see Redefining Security for the Modern Data Center in a Multi-Cloud World.

Cisco Services for Tetration
If requested, Cisco can also provide professional and support services for Tetration SaaS and Tetration-V, including: support for Tetration onboarding and use-case support to accelerate Tetration adoption and optimize policies and security, resulting in a faster time to value with Tetration.  

Availability
Cisco Tetration SaaS is scheduled to be available in May 2018. Tetration-V is available now.

Additional resources   
Learn more about Cisco Tetration
Learn more about Cisco ACI™
Learn more about Cisco ACI ecosystem partners
Learn more about Cisco data center technology
Learn more about Services for Cisco Tetration
 
About Cisco
Cisco (NASDAQ:CSCO) is the worldwide technology leader that has been making the Internet work since 1984. Our people, products, and partners help society securely connect and seize tomorrow's digital opportunity today. Discover more at thenetwork.cisco.com and follow us on Twitter at @Cisco.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. A listing of Cisco's trademarks can be found at www.cisco.com/go/trademarks. Third-party trademarks mentioned are the property of their respective owners. The use of the word partner does not imply a partnership relationship between Cisco and any other company.

RSS Feed for Cisco: http://newsroom.cisco.com/rss-feeds

Press Relations:
Lee Davis 
Cisco
650-868-3036
leedavis@cisco.com           
           
Analyst Relations:
Aimee Schoaf
Cisco
623-377-0377
aschoaf@cisco.com           
          
Investor Relations:
Carol Villazon
Cisco
408-527-6538
carolv@cisco.com

SOURCE: Cisco Systems, Inc.

--BERNAMA

Neuralstem presents clinical update this month in New York

KUALA LUMPUR, April 12 (Bernama) -- Neuralstem Inc´s chief scientific officer, Karl Johe Ph.D will give a clinical update at the Alliance for Regenerative Medicine 6th Annual Cell and Gene Therapy Investor Day in New York on April 17.

The Company has two lead development candidates, NSI-189 - a small molecule in clinical development for major depressive disorder and NSI-566, a stem cell therapy being tested for treatment of paralysis in stroke, Amyotrophic Lateral Sclerosis (ALS) and chronic spinal cord injury (cSCI).

A statement said a live audio webcast as well as a video recording of the presentation will be available in the Investors section of Company´s website at investor.neuralstem.com. The webcast will be archived on the Company's website for 90 days following the presentation.

Neuralstem is a clinical-stage biopharmaceutical company developing novel treatments for nervous system diseases of high unmet medical need.



-- BERNAMA

EMQ PARTNERS WITH KOTAK MAHINDRA BANK TO BOOST INTERNATIONAL REMITTANCES INTO INDIA






HONG KONG & MUMBAI, India, April 10 (Bernama-BUSINESS WIRE) -- EMQ, a fintech innovator with an extensive financial settlement network in Asia today announced a strategic partnership with Kotak Mahindra Bank (Kotak) to expand EMQ’s network footprint in India. This partnership will aid in meeting the growing demand for instant remittances to the country from over 16 million Indians residing abroad.

Max Liu, Co-founder and CEO of EMQ said, “India is one of the most important strategic growth markets for EMQ as it is the largest recipient of remittances in the world with US$65 billion currency flow into the country in 2017, according to the World Bank. Our partnership enables us to provide more accessible and affordable financial services to the millions of Indians based overseas and their families across India.”

Virat Diwanji, Sr. EVP & Head – Branch Banking & Acquisitions, Kotak Mahindra Bank said, “Remittances play a vital role in contributing to India’s economic growth and there is a great demand among our customers for international remittances. Our partnership with EMQ will complement our offerings and further strengthen our capabilities in serving our customers on cross-border payments across EMQ’s extensive financial settlement network.”

“At EMQ, we strive to launch services that add value to our customers with greater flexibility and cost savings. But most importantly, we want to ensure that the people of India who rely on remittances from their loved ones overseas will receive their money fast and securely,” Liu added.

EMQ currently has a footprint in Hong Kong, Indonesia, Vietnam and the Philippines, with plans underway to expand across the fastest growing trade corridors and economic zones, spanning Asia, Europe, North America and the Middle East. The company received its Money Service Operator license from the Hong Kong Customs and Excise Department in September 2014 and its Fund Transfer Operator license from Bank Indonesia in March 2017.

About EMQ

EMQ is a financial settlement network in Asia, providing secure and affordable money transfer options for businesses and individuals. With our assets anchored in Asia, EMQ has established an extensive and regulatory-approved network that provides immediate access to thousands of distribution points across North and Southeast Asia. For more information, please visit EMQ’s website at www.emq.com

About Kotak Mahindra Bank

Established in 1985, Kotak Mahindra Group is one of India's leading financial services conglomerates. In February 2003, Kotak Mahindra Finance Ltd. (KMFL), the Group's flagship company, received banking license from the Reserve Bank of India (RBI), becoming the first non-banking finance company in India to convert into a bank - Kotak Mahindra Bank Ltd.

Effective April 1, 2015, ING Vysya Bank Ltd. merged with Kotak Mahindra Bank Ltd. As on December 31, 2017, Kotak Mahindra Bank Ltd, has a national footprint of 1,375 branches spread across 700 locations and 2,171 ATMs.

The Bank has four Strategic Business Units – Consumer Banking, Corporate Banking, Commercial Banking and Treasury, which cater to retail and corporate customers across urban and rural India.

For more information, please visit the company’s website at http://www.kotak.com/. 

Wednesday, April 11, 2018

SevOne provides solution for Cisco ACI based infrastructure

KUALA LUMPUR, April 11 (Bernama) -- SevOne today unveiled its SevOne SDN Monitoring Solution 2.0 for Cisco Application Centric Infrastructure (Cisco ACI).

The new solution automates operational insight, helping to unlock the true value of the application agility and data center automation provided by Cisco's ACI-based infrastructure, a statement said.

With the new offering, IT teams can now access real-time and historical insight into tenant and end-point group relationships and health scores; multi-APIC Cluster statuses; as well as fabric capacity analysis which all combined with metadata enrichment.

It delivers new interactive dashboards for unparalleled visibility by network operations and engineering teams into the health, performance and status of the virtual overlay and the physical underlay of single and multi-cluster Cisco ACI deployments.

The SevOne SDN Monitoring Solution for Cisco ACI also ease the transition to ACI whereby users are able to monitor their existing traditional network and new software-defined infrastructure from the same dashboard.

The benefit of assesses business impact make users understand how infrastructure performance affects the applications and services available in their Cisco ACI deployment.

In addition, it also easily extend visibility to other critical data center assets such as firewalls and load balancers, or across the campus to wide area networks and branch offices.

"The SevOne SDN Monitoring Solution for Cisco ACI provides performance metrics from both the existing, traditional network and the new software-defined network on a single, easy-to-read dashboard," said senior vice-president, Marketing & Corporate Development SevOne, Jim Melvin.

Director, Data Center Networks Cisco, Ranga Rao said by combining ACI with the SevOne SDN Monitoring Solution, organisations can gain additional operational insight that is easily scalable for growth.

SevOne is a leading provider of network and infrastructure management solutions. More information can be accessed at www.sevone.com.

--BERNAMA

OMNICOMM SYSTEMS SIGNS FIRST TRIALMASTER® CUSTOMER IN CHINA

Shanghai HEP Pharma Selects TrialMaster EDC to Conduct Hepatitis B Study
 
FORT LAUDERDALE, Fla., April 11 (Bernama-GLOBE NEWSWIRE) --Shanghai HEP Pharma Co. LTD, a research and development company focused on developing innovative drugs for hepatitis B, has signed a new agreement with OmniComm Systems, Inc. (OTCQX:OMCM), a leading global provider of clinical data management technology. Under the agreement, Shanghai HEP Pharma will use OmniComm’s TrialMaster EDC technology for a randomized Phase II/Phase III hepatitis B study.  
 
The agreement represents OmniComm’s first TrialMaster deal in China. More than two years ago, OmniComm established a goal of developing a presence in the Chinese market, and to-date the company’s performance in that sector has met expectations. The expanded footprint in the Asia-Pacific region includes OmniComm’s first contract for TrialMaster® in Japan, along with 13 TrialOne® agreements in China.
                                                                                   
As a system that is compliant with global industry standards, TrialMaster allows user organizations to ensure the quality and integrity of the data collected and managed during the entire study. TrialMaster also enables users to comply with the Chinese FDA’s new regulation and approval process for new drug development in China. TrialMaster’s ability to facilitate users’ compliance with CFDA’s regulations aimed at harmonizing local practices to global standards was also a key factor.
 
“From our research and development pipeline, we have developed this hepatitis B drug from the concept stage,” said Dr. Hongli Liu, CEO of Shanghai HEP Pharma. “This hepatitis B drug is a critical product for us, and we wanted to select a high quality and global standard EDC system to ensure our study is well managed. We had excellent experience using OmniComm’s Phase I system, Promasys®, which naturally led to TrialMaster, OmniComm’s Phase II/III EDC system. We look forward to working with OmniComm’s team on study build and are confident to hit First Patient In date on time.”
 
“We are very excited about our first deployment of TrialMaster in China, and it is with a highly innovative biotechnology company,” said Kuno van der Post, Ph.D., chief commercial officer, OmniComm Systems. “We are delighted that we were selected in a highly competitive evaluation.”

About OmniComm Systems, Inc. 
OmniComm provides comprehensive solutions for clinical research with an extensive global experience from more than 6,000 clinical trials. For more information, visit www.omnicomm.com.
 
Contact Info
Kuno van der Post
OmniComm Systems, Inc. 
+1.954.473.1254
KvanderPost@omnicomm.com
 
SOURCE: OmniComm Systems Inc.
 
--BERNAMA

http://mrem.bernama.com/viewsm.php?idm=31646